Swiss National Bank Takes $784,000 Position in Nutex Health Inc. $NUTX

Swiss National Bank acquired a new stake in Nutex Health Inc. (NASDAQ:NUTX) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,300 shares of the company’s stock, valued at approximately $784,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Nutex Health in the 2nd quarter worth about $750,000. Intech Investment Management LLC bought a new stake in shares of Nutex Health during the 2nd quarter valued at about $211,000. Calamos Advisors LLC acquired a new stake in Nutex Health during the second quarter worth about $242,000. Police & Firemen s Retirement System of New Jersey bought a new position in Nutex Health in the second quarter worth about $97,000. Finally, Geode Capital Management LLC boosted its stake in Nutex Health by 116.8% in the second quarter. Geode Capital Management LLC now owns 78,859 shares of the company’s stock valued at $9,819,000 after acquiring an additional 42,484 shares during the period. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Price Performance

Shares of Nutex Health stock opened at $168.42 on Wednesday. Nutex Health Inc. has a 52 week low of $28.12 and a 52 week high of $187.20. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67. The stock has a market cap of $1.19 billion, a PE ratio of 9.11 and a beta of -0.03. The company’s 50-day moving average price is $119.68 and its two-hundred day moving average price is $112.02.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share for the quarter, topping analysts’ consensus estimates of ($5.43) by $13.19. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%. The firm had revenue of $243.99 million during the quarter, compared to analysts’ expectations of $221.93 million.

Analysts Set New Price Targets

A number of analysts have recently weighed in on NUTX shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Nutex Health in a research report on Monday. Wall Street Zen upgraded Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Finally, Maxim Group set a $205.00 price objective on shares of Nutex Health and gave the stock a “buy” rating in a report on Tuesday, August 26th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Nutex Health currently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Insider Activity

In related news, CFO Jon Christian Bates bought 750 shares of Nutex Health stock in a transaction dated Tuesday, November 25th. The stock was acquired at an average cost of $136.71 per share, with a total value of $102,532.50. Following the completion of the acquisition, the chief financial officer directly owned 5,638 shares in the company, valued at approximately $770,770.98. This trade represents a 15.34% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 36.92% of the stock is owned by company insiders.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.